Saturday 17 October 2026
Export CANOQ’s income statement to Excel — free account
Cano Health, Inc.
CANOQ Healthcare Medical Care Facilities
Cano Health, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $3.1 billion, up 14.6% from fiscal 2022. Revenue growth for five consecutive years, operating cash flow growth for three.
0.24
0.00
0.00%
Follow CANOQ
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(2.84) | 0.67 | 1.26 | — | — | — |
P/S ratio |
0.00 | 0.09 | 0.94 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(17.83) | (1.19) | 0.56 | (0.01) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(7.85) | (2.68) | (1.49) | — | — | — |
P/Operating CF |
(0.32) | (3.95) | (64.54) | 9,795.16 | 0.00 | — |
P/B ratio |
0.00 | 0.50 | 1.90 | 2,330.71 | 0.00 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
(0.01) | 0.47 | 1.42 | 0.00 | 0.00 | — |
EV/EBITDA |
0.07 | 0.00 | 0.00 | 7,027.74 | 0.00 | — |
EV/Operating CF |
0.19 | (8.75) | (19.41) | (12,574.59) | 0.00 | — |
EV/FCF |
0.16 | (6.54) | (15.03) | (5,450.15) | 0.00 | — |
Quick Ratio |
0.12 | 1.25 | 1.84 | 1.51 | 0.00 | — |
Current Ratio |
0.13 | 1.63 | 1.97 | 1.65 | 0.00 | — |
Net Debt/EBITDA |
0.10 | (53.56) | (9.54) | 18.62 | 0.00 | — |
Debt/Assets |
5.45% | 55.10% | 43.61% | 81.22% | 0.00% | 0.00% |
Debt/Equity |
(0.10) | 2.15 | 1.17 | 10.05 | 0.00 | — |
Asset Turnover |
2.13 | 1.35 | 1.17 | 2.71 | 15,850.18 | — |
Operating CF/Net income |
0.22 | 0.71 | 6.55 | 0.13 | 0.78 | — |
Capex/Depreciation |
(0.03) | (0.12) | (0.63) | (0.48) | (1.26) | — |
Interest Coverage |
(8.75) | (6.99) | (2.64) | (0.01) | (0.95) | — |
| 2,919.11% | (32.06%) | (4.25%) | (286.43%) | (79.12%) | — | |
| (40.40%) | (10.18%) | (1.31%) | (23.14%) | (86,754.39%) | — | |
ROIC |
0.00% | (17.84%) | (5.38%) | (0.03%) | 0.00% | — |
Return on Tangible Assets |
50.46% | (78.62%) | (7.46%) | (86.70%) | 38,860.51% | — |
Average Days of Receivables |
8.82 | 31.16 | 30.26 | 29.56 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
11.56% | 15.42% | 15.67% | 12.50% | 16.37% | — |
Intangible Assets out of Total Assets |
0.68 | 0.66 | 0.74 | 0.75 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.26% | 2.00% | 1.74% | 0.06% | 0.05% | — |
Graham Net Nets |
(94.83) | (4.46) | (0.68) | 0.00 | 0.00 | — |
Graham Number |
1,059.04 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(4,906.41%) | (77.68%) | (2.27%) | (0.03%) | 0.00% | — |
Free Cash Flow Yield |
(1,029.45%) | (79.79%) | (10.03%) | (0.02%) | 0.00% | — |
Revenue per Share |
1,139.30 | 1,249.68 | 943.86 | 0.00 | 0.00 | — |
Operating CF per Share |
(46.86) | (66.77) | (69.22) | 0.00 | 0.00 | — |
Capex per Share |
(6.98) | (22.60) | (20.15) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(53.84) | (89.37) | (89.37) | 0.00 | 0.00 | — |
Cash per Share |
34.10 | 12.47 | 95.70 | 0.00 | 0.00 | — |
Shareholders Equity per Share |
(194.26) | 225.52 | 468.34 | 0.00 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(194.26) | 225.52 | 468.34 | 0.00 | 0.00 | — |
Free Cash Flow |
(148.28) | (195.87) | (152.39) | (21.31) | (24.77) | — |
Working Capital |
(1,232.60) | 132.31 | 156.20 | 43.84 | (0.05) | — |
Capital Expenditures |
(19.23) | (49.53) | (34.35) | (12.07) | (9.31) | — |
Net Current Asset Value |
(1,365.92) | (1,093.90) | (1,027.74) | (453.55) | (0.05) | — |
EV/EBIT |
0.02 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.01 | 0.03 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||
Depreciation/Fixed assets |
11.61 | 3.18 | 0.64 | 0.66 | 0.00 | — |
Cash ROIC |
38.43% | (12.36%) | (8.03%) | (3.66%) | 467,452.83% | — |
Accounts Receivable Turnover |
20.27 | 14.92 | 16.03 | 8.32 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | — |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | — | — |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | — | — |
Average Receivables |
154.81 | 183.62 | 100.39 | 100.00 | — | — |
Average Payables |
107.04 | 93.28 | 56.10 | 52.00 | — | — |
Average Inventory |
— | — | 0.96 | 1.00 | — | — |
Average Assets |
1,471.33 | 2,036.23 | 1,378.86 | 307.12 | 0.02 | — |
Average Common Equity |
(20.36) | 646.42 | 424.10 | 24.81 | 25.00 | — |
Columns are period end dates